Weekend reading | Zuckerberg and Ultraman launch the "second chip war".

Looking back at 2024 and looking forward to 2025, let insights transcend time to seek certainty for the future. This issue focuses on the chip networks and computing power of Silicon Valley giants.

Tencent Technology36minutes ago

By increasing shareholding in Occidental Petroleum, Buffett has contradicted one of his principles.

According to estimates from Barron's, reducing the shareholding in Apple caused Buffett to miss out on over $35 billion in earnings. Meanwhile, Occidental Petroleum and Sirius XM have both seen significant declines this year, with stock prices consistently below Berkshire's average buying cost. Buffett seems to be "pulling flowers and watering weeds."

Barun Chinese09:37

Deal Dispatch: Honeywell, Textron And Soho House Are Making M&A Moves

Benzinga05:00

Eli Lilly and Co's Zepbound has been approved by the FDA for the treatment of obstructive sleep apnea.

① The FDA in the USA approved Eli Lilly and Co's weight loss medication Zepbound on Friday for the treatment of obstructive sleep apnea (OSA), making it the first drug approved for directly treating this common sleep disorder; ② The active ingredient in Zepbound is Tirzepatide, which was initially used to treat type 2 diabetes, namely Eli Lilly and Co's Mounjaro.

cls.cn04:45

Google Announces Major Layoffs As Pichai Stresses Efficiency

Benzinga04:15

OpenAI Project to Improve ChatGPT Behind Schedule as Costs Soar: Report

Seeking Alpha03:49